关于LTCCB与心血管疾病之间的相关性研究的进展:一篇综述
1The First Clinical Medical College of Gansu University of Traditional Chinese Medicine, Lanzhou City, Gansu Province, People's Republic of China.
Medicine
|June 23, 2025
概括
L型通道阻断剂 (LTCCB) 对于治疗高血压和心律失常等心血管疾病至关重要. 本综述探讨了LTCCB的情况.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 生物医学研究生物医学研究
背景情况:
- 心血管疾病 (CVD) 是一个日益严重的全球健康挑战.
- 药理疗法在控制心血管疾病进展和改善患者的治疗结果方面变得越来越重要.
- L型通道阻断剂 (LTCCB) 已成为心血管药物治疗中的重要研究领域.
研究的目的:
- 审查L型通道阻断剂 (LTCCB) 在心血管医学中的多方面的作用.
- 探索LTCCBs在包括高血压,心律失常,缺血-再输血损伤和心肌病在内的疾病中的治疗应用.
- 为未来的研究和基于LTCCB的治疗方法的临床实施提供理论基础.
主要方法:
- 对L型通道阻断剂的现有研究进行了全面的文献综述.
- 对药物试验数据的分析和LTCCBs的临床应用.
- 讨论LTCCB治疗当前的局限性和未来的方向.
主要成果:
- LTCCBs在一系列心血管疾病中显示出显著的治疗潜力.
- LTCCB药物类型的多样性已经扩大,提供了更多的治疗选择.
- 确定在LTCCB药物处理过程和应用场景中需要改进的关键领域.
结论:
- L型通道阻断剂是现代心血管疾病管理的组成部分.
- 预计LTCCB的持续研究和开发将提高复杂心血管疾病的诊断和治疗策略.
- 这一审查有助于多样化治疗选择,并指导未来的临床实践.
相关概念视频
01:30Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
01:26Coronary Artery Disease IV: Preventive Measures
39
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
39
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
129
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
129
01:26Coronary Artery Disease II: Pathophysiology
42
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
42
01:26Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
52
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
52